Sure, better PR with better connections probably c

Sure, better PR with better connections probably could have done a better job but we don't have that at our disposal right now. Working the social media streets, emailing reporters, or whatever each of us does really can have an impact.

If investors chose to never speak of the leronlimab story we'd have far fewer shareholders. I can imagine the average number of people any one of us has gotten into CYDY being greater than 5. I'm at 10. That happens because we are passionate about our investment and because the people we choose to talk to about it find something compelling to get on board with.

The author of the Wired article, in her bio at the end, says that she's a "writer and meta-scientist with expertise in assessing the validity of evidence for health claims." She seems like the perfect kind of target for an email about Leronlimab. Reporters and scientists are always interested in uncovering things, breaking stories, positing new theories, etc. Most are, at least. I'm sure some just want a paycheck and to be left alone. But the point is that targeting the media can have an effect. Navigating the media rapids with two oars is easier, but as long as you got one oar you can make headway.